首站-论文投稿智能助手
典型文献
Protective effects and mechanisms of Lizhong decoction(理中汤)against non-alcoholic fatty liver disease in a rat model
文献摘要:
OBJECTIVE:To investigate the protective effects and molecular mechanisms of Lizhong decoction(理中汤,LZD)against non-alcoholic fatty liver disease(NAFLD).METHODS:Male Wistar rats were fed a high-fat diet for four weeks to induce NAFLD,and were administered LZD by gavage for four weeks.Potential therapeutic targets for NAFLD were analyzed using network pharmacology.Liver pathology was evaluated using Oil Red O and hematoxylin-eosin staining.Furthermore,mitochondrial function,lipid metabolism,oxidative stress,and inflammatory response were examined.RESULTS:Rats with NAFLD exhibited high levels of hepatic damage and cholesterol deposition.Moreover,apoptosis was increased,superoxide dismutase and glutathione content were reduced,malondialdehyde content was increased,and the protein expression of inflammatory cytokines and p-c-Jun N-terminal kinase was increased.The LZD treatment ameliorated mitochondrial dysfunction,reduced liver damage,inhibited oxidative stress and inflammatory response,upregulated peroxisome proliferator-activated receptor(PPAR)-γ expression,and suppressed dipeptidyl peptidase 4(DPP4)expression in the liver.CONCLUSION:It was found that LZD alleviates NAFLD by activating PPAR-γ and inhibiting DPP4.
文献关键词:
作者姓名:
YANG Jiayao;TAO Dongqing;MA Wei;LIU Song;LIAO Yan;SHU Lei;ZHANG Shu;LI Chenyu;DU Nianlong
作者机构:
Department of Gastroenterology,Wuhan Integrated TCM and Western Medicine Hospital,Wuhan 430022,China;Department of Endocrinology,The Third People's Hospital of Hubei Province,Wuhan 430033,China;Department of Center Laboratory,Wuhan Integrated TCM and Western Medicine Hospital,Wuhan 430022,China;Hubei University of Traditional Chinese Medicine,Wuhan 430065,China
引用格式:
[1]YANG Jiayao;TAO Dongqing;MA Wei;LIU Song;LIAO Yan;SHU Lei;ZHANG Shu;LI Chenyu;DU Nianlong-.Protective effects and mechanisms of Lizhong decoction(理中汤)against non-alcoholic fatty liver disease in a rat model)[J].中医杂志(英文版),2022(05):773-780
A类:
Lizhong
B类:
Protective,effects,mechanisms,decoction,理中汤,against,alcoholic,fatty,liver,disease,model,OBJECTIVE,To,investigate,protective,molecular,LZD,NAFLD,METHODS,Male,Wistar,rats,were,fed,high,diet,four,weeks,induce,administered,by,gavage,Potential,therapeutic,targets,analyzed,using,network,pharmacology,Liver,pathology,was,evaluated,Oil,Red,hematoxylin,eosin,staining,Furthermore,mitochondrial,lipid,metabolism,oxidative,stress,inflammatory,response,examined,RESULTS,Rats,exhibited,levels,hepatic,damage,cholesterol,deposition,Moreover,apoptosis,increased,superoxide,dismutase,glutathione,content,reduced,malondialdehyde,protein,expression,cytokines,Jun,terminal,kinase,treatment,ameliorated,dysfunction,inhibited,upregulated,peroxisome,proliferator,activated,receptor,PPAR,suppressed,dipeptidyl,peptidase,DPP4,CONCLUSION,It,found,that,alleviates,activating,inhibiting
AB值:
0.629066
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Asiatic acid alleviates ischemic myocardial injury in mice by modulating mitophagy-and glycophagy-based energy metabolism
Fan Qiu;Yi Yuan;Wei Luo;Yan-shan Gong;Zhong-ming Zhang;Zhong-min Liu;Ling Gao-Translational Medical Center for Stem Cell Therapy&Institute for Regenerative Medicine,Shanghai East Hospital,Tongji University School of Medicine,Shanghai 200123,China;Department of Cardiovascular and Thoracic Surgery,Shanghai East Hospital,Tongji University School of Medicine,Shanghai 200120,China;Department of Cardiovascular and Thoracic Surgery,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221006,China;Shanghai Institute of Stem Cell Research and Clinical translation,Shanghai East Hospital,Tongji University,Shanghai 200120,China;Shanghai Engineering Research Center for Stem Cell Clinical Treatment,Shanghai 200123,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。